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Pathogenesis and Prevention of 
Fetal and Neonatal Brain Injury
Andrew Macnab
Abstract
Recent advances in the clinical management of at-risk pregnancy and care of the 
newborn have reduced morbidity and mortality among sick neonates, and improved 
our knowledge of factors that influence the risks of brain injury. In parallel, the 
refinement of imaging techniques has added to the ability of clinicians to define the 
etiology, timing and location of pathologic changes with diagnostic and prognostic 
relevance to the developing fetus and newborn infant. Abnormalities of brain 
growth, or injury to the developing brain can occur during pregnancy; during labor 
and delivery, hypoxia, acidosis and ischemia pose major risks to the fetus. Defined 
practices for the management of pregnancy and delivery, and evidence-based strate-
gies for care in the newborn period are influencing outcome. However, newborn 
infants, especially those born prematurely, remain at risk from situations that can 
cause or worsen brain injury. The literature reviewed here explains the mechanisms 
and timing of injury, and the importance of hypoxia, ischemia, hypotension and 
infection; describes current diagnostic strategies, neuroimaging technologies 
and care entities available; and outlines approaches that can be used to prevent or 
mitigate brain injury. Some show particular promise, and all are relevant to lowering 
the incidence and severity of brain damage.
Keywords: encephalopathy, hypoxia, ischemia, magnetic resonance imaging, 
prematurity, ultrasound, umbilical cord blood gases
1. Introduction
“This work must begin with the conception of man, and describe the nature of 
the womb and how the foetus lives in it, up to what stage it resides there, and in 
what way it quickens into life and feeds. Also, its growth and what interval there is 
between one stage of growth and another. What it is that forces it out from the body 
of the mother, and for what reasons it sometimes comes out of the mother’s womb 
before the due time.”—Leonardo da Vinci (1452-1519) [1].
In a prior review (2012), literature describing the etiology of fetal brain injury, 
and its presentation, evolution and management in the neonate was summarized 
[2]. However, recent advances have considerably increased our knowledge of the 
nature and prognosis of brain injury, and what can be done to treat and prevent it.
The importance of maternal and fetal health throughout the nine months 
of intrauterine life remains. But the vulnerability of the fetus to adverse events 
related to labor and delivery is better understood, and more readily antici-
pated. Substantial progress has also been made in the care of neonates, our 
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understanding of the pathogenesis of injury, and protective strategies which 
can help to prevent or mitigate permanent injury. It is now clear that acute brain 
injury is a continuum; hypoxia and ischemia in particular generate a sequence of 
physiologic consequences where the acute phase of injury is followed by a period 
of latency, and then brain cells undergo secondary energy failure where a cascade 
of disruptive events occurs which leads ultimately to programmed cell death. This 
understanding is particularly valuable, as it now guides investigation linked to 
both the diagnosis and prognosis of injury, and provides critical opportunities for 
novel care strategies.
The birth and care of infants born prematurely remains challenging. The 
inherent immaturity of their organ systems and complex therapies they require 
makes them vulnerable physiologically to a spectrum of potentially adverse events; 
the result is a significant incidence of long-term cognitive and motor deficits. In 
spite of advances in obstetric and neonatal care lowering the overall prevalence of 
complications, the incidence of cerebral palsy has not reduced significantly. But it 
is clear now that a strong relationship exists between gestational age at delivery and 
the probability of both survival and discharge without major handicap, with every 
additional week in utero tending to improve the chances of a good outcome [3].
Fetal and neonatal brain injury, and the long-term neurodevelopmental 
handicap caused, is an extremely important problem, and especially so in prema-
ture infants, because of the large absolute number born. Research documents that 
infants born very prematurely (<32 weeks gestation), and those with an extremely 
low birth weight (<1000 g), are at increased risk for neurobehavioral impairments 
(cerebral palsy, blindness, deafness), lower general intelligence, specific cogni-
tive defects, learning disabilities, and behavioral and emotional problems [2, 3]. 
Modern neonatal care does now enable an increasing number of these infants to 
survive and escape significant handicaps. Survival of extremely preterm infants 
(<25 weeks gestation) remains rare, but in Europe and the USA 75-90% of infants 
who weigh <1500 g at birth now survive, however 5-10% of them develop cerebral 
palsy subsequently, and many have cognitive, behavioral, attention-related or 
socialization deficits.
Normal fetal growth is a continuum that must be appreciated in order to fully 
understand the causes, evolution, and consequences of abnormalities in brain 
development. Key factors have been reviewed previously [2]. Genetic anomalies are 
the principal cause of fetal loss, and structural abnormalities are commonly evident 
at a macroscopic and microscopic level. Advances in genetic screening and analysis 
have led to genetic studies becoming an integral part of the workup of an increasing 
number of infants. Genetic counseling is central to prevention in situations where 
there is a family history of a genetic brain abnormality, birth of a prior infant with an 
anomaly, or predisposition to a genetic problem due to racial or age-related factors. 
An autopsy and placental pathology are important after fetal loss.
Embryonic development progresses rapidly after conception, so that a large pro-
portion of the brain’s structure is already formed by the time many women become 
aware that they are pregnant. By the end of the first trimester (3 months of gesta-
tion), all the main structures of the central nervous system are formed and so brain 
growth alone follows between this time and fetal maturity (40 weeks). Hence the 
relevance of more people understanding the concepts currently articulated in the 
developmental origins of health and disease (DOHaD) [4] and the importance of:
• health at the time of conception (both paternal and maternal);
• the detrimental effects on the fetal brain of drugs, alcohol and nicotine;
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• the beneficial effects of a maternal diet that provides essential nutrients
• maternal nutrition and weight gain that avoids fetal stunting or overweight
Impaired fetal growth secondary to poor maternal nutrition or placental insuf-
ficiency can be associated with reduced brain development; growth retarded infants 
are at increased risk of hypoxic stress and hypoxic ischemic (HI) brain injury due 
to altered placental blood flow and sub-optimal fetal oxygenation, particularly at 
the time of delivery. Suboptimal nutrition also poses the risk of hypoglycemic brain 
injury immediately after birth; the impact of this form of brain injury can now 
be defined through neuroimaging [5]. At the opposite end of the spectrum, being 
large for gestational age, post mature, or the product of a multiple pregnancy poses 
unique challenges, and increases the risk of HI injury [2]. In addition, surviving 
infants born small or large for gestational age are at increased risk of developing 
adult-onset chronic diseases (e.g. hypertension, cardiovascular disease, stroke, type 
2 diabetes, obesity); the current epidemic of non-communicable diseases has been 
shown to be linked to early stunting of growth and excessive infant weight gain [4].
Importantly many of the causes of brain damage are now avoidable or amenable 
to treatment. Neuroimaging protocols help to define both the timing and geo-
graphic location of injury, and document the evolution of neuronal changes through 
defined phases over time [6, 7]. In the acute phase, damage follows decreased cere-
bral blood flow and reduced oxygen and glucose delivery and resulting ischemia 
and acidosis. A period of latency follows with transient recovery of energy metabo-
lism. Then an ‘excito-oxidative’ cascade leads to cerebral energy failure and pro-
gression to cell death [8–10]. In this phase, reduced adenosine triphosphate (ATP) 
production affects membrane integrity; intracellular accumulation of sodium and 
water follows, and brain cell injury is caused by neuronal depolarization, glutamate 
release, an influx of calcium, and release of toxic nitric oxide free radicals. The 
‘therapeutic window’ offered by the ‘latent phase’ now allows interventions to 
ameliorate the effects of HI injury, and hypothermia initiated within 6 hours of age 
shows particular promise.
2. Predisposing factors for brain injury
Hypoxia is central to the genesis of much of the brain injury that occurs in 
the fetus. Compromised oxygen delivery is a particular risk during labor and 
delivery, but the fetus is at risk whenever brain ischemia occurs due to impaired 
cerebral blood flow (CBF). After ischemic injury, reperfusion can potentially cause 
additional injury or complicate recovery, as can any situations that compromise 
normal brain perfusion further, including disturbance of oxygen delivery and/or 
carbon dioxide transport, acid base status, or the supply of energy and metabolites 
required for normal brain function. Resuscitation of a newborn neurologically 
depressed by intrapartum asphyxia is such a situation, and ongoing brain injury 
will occur until effective cardiac output, cerebral perfusion and oxygen transport 
are restored.
Clinical effects of hypoxia include a disturbance of acid base status. An unre-
lieved hypoxic event in the fetus causes progressive acidosis which leads to systemic 
organ dysfunction, including cardiac depression, where compromised contractility 
and filling reduce cardiac output leading to a reduction in CBF and high risk of brain 
insult when cerebral hypoxia and ischemia occur. Importantly, cardiac functional 
impairment can precede depression of fetal heart rate. Hypoxic insults depress brain 
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function, so following intrapartum insults infants are neurologically abnormal at 
birth, often require resuscitation to initiate breathing, and cardiovascular support 
can be needed to stimulate heart function and provide adequate blood pressure 
and circulation. Tone and behavior usually remain abnormal on admission to the 
nursery; encephalopathy developing in the hours or days after birth is confirmation 
that a significant HI insult resulting in brain injury has occurred.
Hypoxic ischemic brain injury is estimated to occur in about 3 out of every 1000 
births [8]. Diagnostic features include problems with level of consciousness, tone, 
respiratory drive, and coordination of sucking and swallowing, and seizure activity 
which is commonly refractory. In the longer term, the consequences of injury vary 
between death (15-20%) and complete recovery, with the spectrum of permanent 
brain injury ranging from mild motor and cognitive defects, to cerebral palsy and 
severe cognitive disabilities. The pattern and consequences of injury depend on the 
severity and duration of the insult. The neurovascular and anatomical maturity of 
the brain relative to the gestational age of the fetus is also a primary factor; co-
related elements include the adequacy of metabolic reserves available to the fetus to 
compensate for oxidative stress, the presence or absence of infection, and pre-
existing abnormalities in brain growth and development. Different regions of the 
fetal brain and individual cell lines have gestation specific vulnerability to damage.
Prematurity: The 10% of infants born prematurely are at particular risk for 
brain injury; their neurovascular anatomy has limited development making them 
vulnerable to fluctuations in brain blood flow and oxygen delivery. In those very 
immature, the brain lacks both the duplication of blood supply that develops as a 
fetus matures, and the ability to auto-regulate CBF in response to fluctuations in 
systemic blood pressure. Vascular complexes in areas such as the germinal matrix 
are vulnerable to bleeding when blood pressure fluctuates, and perturbations 
insufficient to cause damage in a more mature fetus may generate injury; bleeding 
is often related to asphyxial stress, and can result from complications of treatment 
entities very preterm infants require. Mechanisms underlying this form of injury 
include: variations in cerebral venous pressure, major cerebral vasodilatation or 
constriction, altered distribution of CBF, systemic fluctuations in circulating blood 
volume, and significant changes in either oxygen or carbon dioxide tension [11].
Periventricular leukomalacia (PVL) is predominately a condition affecting 
the preterm infant. The primary causal mechanism is HI injury, with ischemia 
being the major component. PVL acquired intrapartum is usually associated with 
abnormal neurological findings at birth, but may manifest as lower limb weakness 
evident in the first weeks of life. PVL can be aggravated by, or generated as a result 
of postnatal events. Neurobiologic research has shown that maturational dependent 
oligodendroglial precursor cells are a major target in PVL, and these are exquisitely 
vulnerable to damage by free radicals generated during ischemia and reperfusion. 
PVL is associated with intraventricular hemorrhage (IVH) in approximately 25% of 
cases. The pathogenesis of IVH is usually multifactorial, and related to: fluctuating 
CBF; increased cerebral venous pressure; decreased CBF followed by reperfusion; 
and disorders of coagulation, platelet function and capillary integrity [11].
The commonest clinical situation where pathogenic factors combine to generate 
sufficient ischemia to cause PVL is when a sick preterm infant requires mechanical 
ventilation, and problems occur during ‘uncontrolled’ intubation, with ‘fighting the 
ventilator,’ or when a pneumothorax (air leak) compresses the lung, which raises 
intrathoracic pressure and disrupts normal blood return to the heart; in turn, this 
reduces cardiac output and brain blood flow. Vascular factors are also relevant; 
blood transfusion or rapid IV volume replacement pose potential risk due to the 
pressure passive nature of the immature cerebral circulation; systemic variations in 
blood pressure, sequelae of sepsis, and the cerebral effects of hypocarbia can render 
5Pathogenesis and Prevention of Fetal and Neonatal Brain Injury
DOI: http://dx.doi.org/10.5772/intechopen.93840
an infant symptomatic. Many infants with PVL have a normal neurologic outcome. 
Those with permanent sequelae exhibit a range of problems with varying degrees of 
severity; including intellectual and visual deficits, usually superimposed on spastic 
paresis involving the extremities, where the lower limbs are predominantly affected.
In late prematurity (34 weeks to 36 weeks plus 6 days gestation), the vulnerabil-
ity of the brain to injury,  and the pattern of damage commonly seen are different, 
due to increased structural and functional maturation; at 34 weeks of gestation 
the brain has 65% of its term volume compared to 13% at 28 weeks, and a fivefold 
increase in white matter volume occurs between 35 and 41 weeks of gestation.
Low birth weight (LBW) infants are those born <2500 g. and comprise infants 
born prematurely but appropriately grown for gestational age, and those who are 
small because of intrauterine growth retardation (IUGR). LBW is further divided into 
very low birth weight (<1500 g) and extremely low birth weight (<1000 g). Globally 
14.6% of infants born are LBW (5-10% in industrialized countries); UNICEF data 
indicate that LBW infants have a disproportionate death rate and high intrapartum 
morbidity. Brain injury is caused by many factors, e.g. placental dysfunction and acute 
compromise of placental gas exchange, and risks in the newborn period due to the 
causal factors for their small size. Long-term, neurodevelopmental problems occur.
Extremely low birthweight (ELBW) infants are often born close to the limit 
of viability. Many who survive are at risk of brain injury and neurodevelopmental 
handicaps; however, advances in care have led to a substantial reduction in severe 
morbidity, with clear benefits evident for ELBW infants of higher gestation [3]. 
Consequently, gestational age is a factor that continues to drive interventions aimed 
at prolonging pregnancy. Where such treatment is an option and fetal wellbeing can 
be sustained, there are clear benefits for the fetus of longer gestation. Data from a 
national, prospective, population-based cohort study conducted in all maternity 
and neonatal units in France in 2011 indicate that survival to discharge, and survival 
without any severe adverse outcome are both gestation dependent (Table 1).
Small and large for gestational age (SGA/LGA) infants are those born below 
the 10th and above the 90th centiles respectively. Hypoxic composite neonatal 
morbidity is more common among SGA neonates and traumatic–composite neo-
natal morbidity more common with LGA. In symmetrically growth-retarded SGA 
infants, brain size and function are affected; long-term deficits in neural connec-
tivity and cognitive problems can result. Fetal glucose is determined by maternal 
levels, but impaired glucose metabolism occurs with SGA where hepatic glycogen 
stores are low at birth, and in LGA associated with maternal gestational diabetes [2].
Placental pathology underlies many causes of compromised fetal growth and 
development and intrapartum hypoxia, e.g. decreased maturation of the terminal 
villi is associated with injury to the white matter/watershed areas and basal ganglia 
[12]; also, conditions that can cause fetal death (toxemia in pregnancy, twin to twin 
transfusion syndrome (TTTS), hemorrhage from placenta previa and placental 
abruption and fetal stroke) [13, 14]. Strokes occur between 14 weeks gestation and 
delivery. Etiology is often obscure; ischemic, thrombotic or hemorrhagic injury 
occurs; causes include maternal platelet abnormalities, trauma, TTTS, medication 
(warfarin and some antiepileptic drugs decrease vitamin K dependent coagulation 
Gestation in weeks 23 24 25 26 27-31 32-34
Percentage of survivors 0% 11.6% 30% 47.5% 81.3% 96.8%
Table 1. 
Gestation-related survival without grade 3/4 intraventricular hemorrhage, cystic periventricular 
leukomalacia, retinopathy of prematurity stage 3 or higher, severe bronchopulmonary dysplasia, or necrotizing 
enterocolitis stage 2-3 [3].
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factors), parvovirus B19 and cytomegalovirus infections, and protein C deficiency 
[15, 16]. Diagnosis in utero can be made by ultrasound (US); magnetic resonance 
imaging (MRI) is the optimal imaging modality [16].
Twin to twin transfusion syndrome (TTTS) occurs in up to 1:4 monocho-
rionic diamniotic twin pregnancies; nearly 100% have placental vascular anasto-
moses; most are hemodynamically balanced, but severe complications result when 
there is a chronic net transfusion imbalance between fetuses. Hemodynamically 
significant shunts classically manifest in the mid trimester; while subtle initially, 
cardiovascular effects do impact both recipient and donor twins and are an impor-
tant factor contributing to morbidity and mortality [13, 17]; 70% of recipient 
twins show echocardiographic evidence of cardiac compromise [18]. Protocols 
for frequent US of at-risk twins are the mainstay of management; these monitor 
onset/progression of complications through defined stages of evolution (Quintero 
stages 1–5), quantify the adverse effects of the altered hemodynamics on each twin, 
and allow perinatal management interventions that have the potential to improve 
fetal morbidity and mortality. US provides assessment of amniotic fluid status, 
measurements of fetal structures, and fetal weight estimates which identify growth 
disparity, and are predictive of birth weight discordance [19]. As the transfusion 
of blood from one twin to the other increases, the donor twin becomes oliguric due 
to decreased renal perfusion, with virtual absence of amniotic fluid; this can be so 
marked it prevents fetal movement giving rise to the term ‘stuck’ twin. In contrast, 
the recipient develops polyhydramnios due to increased urine production. Without 
intervention to treat TTTS, increasing polyhydramnios will ultimately result in pre-
term labor, due to the mechanical forces generated by overdistention of the uterus; 
overall, polyhydramnios is complicated by preterm labor in up to 26% of cases, and 
premature rupture of the membranes (PROM) in up to 19% of cases.
Ischemia is the principal mechanism underlying brain damage; lesions include 
white matter infarction, intra-ventricular hemorrhage, hydranencephaly, and 
porencephaly. In up to 58% of TTTS affected pregnancies combined US evidence is 
reported of antenatally acquired brain abnormalities and IVH, and periventricular 
echogenicity assumed to be perinatally acquired [20]. Fetal MRI can identify CNS 
injury; findings range from ischemic or hemorrhagic lesions in the brain to marked 
dilation of the cerebral venous sinuses secondary to central venous hypertension.
US can also evaluate flow in the umbilical vein (UV) and ductus venosus (DV). 
Normally, the UV blood flow velocity waveform has an even non-pulsating pattern, 
since the pulse waves caused by atrial contractions are not propagated backwards 
through the narrow ductus venosus. However, if the DV widens, the pulse waves 
propagate into the UV and result in a pulsating pattern. UV pulsations were first 
described in fetuses in imminent danger of asphyxia, then in those hydropic due 
to heart failure. In fetuses exposed to chronic hypoxia, UV pulsations predict poor 
outcome [21]. The presence of absent or reversed flow in the DV during atrial systole 
(defined as absent/reversed a-wave) is associated with poor perinatal outcomes 
because of compromise to mechanisms that normally preferentially supply the fetal 
brain with well oxygenated blood. The function of the DV is to shunt a portion of 
the oxygenated blood arriving from the placenta directly to the inferior vena cava, 
allowing oxygenated blood to bypass the liver. Consequently, DV flow plays a critical 
role in preferentially supplying oxygen to the fetal brain, in parallel with the other 
fetal shunts (foramen ovale and ductus arteriosus). And so, US evidence of an 
absent or reversed a-wave in the DV identifies those fetuses who are at the highest 
risk of hypoxic brain injury in utero [13, 22, 23].
The expectation of maternal treatment, even for severe TTTS, is for improve-
ment, with probable resolution in utero [24], including regression of fetal cardio-
vascular pathology and improved myocardial performance. Recovery may take 
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longer in more severely affected pregnancies, but this is not the case in all series. 
Survival, particularly for the recipient twin, is likely to be compromised if treat-
ment is delayed [25] hence the relevance of US surveillance and early diagnosis [17].
Maternal Illness during pregnancy: Some are specific to pregnancy such as 
gestational diabetes; others pre-exist; many have the potential to cause damage, 
or predispose the fetus to independent risks for neurological morbidity [2]. Some 
have well known associations with brain injury; rubella and the TORCH group of 
viruses are examples; TORCH viruses are also a potent cause of perinatal death and 
a particular burden in developing countries; some are amenable to treatment; early 
recognition, including maternal prenatal screening, is a key aspect in management 
[26]. Common upper respiratory tract infections and gastroenteritis, although often 
of concern to pregnant women, are not usually associated with brain injury [27].
Fetal inflammatory response syndrome (FIRS): Inflammatory mediators are 
known to precipitate premature rupture of the membranes (PROM) and preterm 
labor, inflame and cross the placenta, and have been linked to increased risk of 
fetal brain injury and cerebral palsy [28]. In FIRS, maternal systemic inflamma-
tion occurs with activation of the innate fetal immune system and elevation of 
fetal plasma cytokines. Cytokine production usually generates a normal immune 
response, but in the immature fetus and premature infant born after FIRS, the 
complex effects of cytokine activity have been linked to increased infant mor-
bidity and mortality, perhaps because the balance of these agents is imperfectly 
controlled [11].
Many cytokines are vasoactive, so in the immature brain, focal variations in 
brain perfusion could result in local ischemia followed by reperfusion; such per-
turbations may cause cumulative injury to brain white matter due to the primitive 
neuro-vascular architecture, immature autoregulatory control mechanisms, and 
sensitivity of maturational dependent cells to free radical damage. The germinal 
matrix is also particularly vulnerable to variations in brain blood flow and blood 
pressure [11]; consequently, it has been hypothesized that periventricular hemor-
rhage would be more likely to occur in the preterm fetus exposed to FIRS.
The initial literature supported a role for inflammatory mediators in premature 
labor and delivery; linked maternal infection and pro-inflammatory mediators in 
the neonatal systemic circulation with increased risk of periventricular leukoma-
lacia and/or spastic diplegia; emphasized the synergistic role of inflammation and 
hypoxia and ischemia when they occur together; and reported a higher incidence of 
HI brain damage where fetal exposure to maternal inflammation/infection occurred 
[2]. This literature also states: “For the premature fetus, once clinical chorioamnio-
nitis occurs, rates of sepsis, pneumonia, respiratory distress syndrome and death 
are all increased by 2-4-fold and long-term neurologic injury is substantially more 
likely to occur” [29]. Strategies can be used to down-regulate the inflammatory 
response and treat mothers with signs and symptoms of infection; some antibiotic 
therapies reduce cytokine production; because of the independent association of 
elevated maternal temperature with worse fetal outcome, appropriate management 
to control fever is also cited as a treatment of potential benefit [30, 31].
Recent literature reappraises prior FIRS-related research. Isolated cytokine-
mediated injury is not reported in term infants [11], and in the premature newborn, 
newer studies have found the relationship between chorioamnionitis and brain 
injury to be attenuated; this difference may result from heterogeneity of the studies, 
or possibly improved neonatal intensive care [32]. Current literature does conflict 
on whether or not histopathological chorioamnionitis is linked to an increased risk 
of white matter injury and intraventricular hemorrhage, or with abnormalities 
of brain development identifiable via MRI (e.g. variations in cortical thickness). 
But research continues to emphasize that postnatal complications from infections, 
Advancement and New Understanding in Brain Injury
8
particularly when associated with hypotension in the premature newborn, are 
associated with an increased risk of white matter injury [33, 34].
Fetal and neonatal Infection significantly increases the risk of brain injury. 
Mechanisms promoting sepsis include PROM; the risk of fetal infection from 
membrane rupture beyond 18 hours increases (10-fold), as does the occurrence of 
perinatal asphyxia, maternal urinary tract infection and colonization with group 
B Streptococcus [35]. Maternal treatment and prophylactic antibiotics given in 
anticipation of sepsis to the infant at birth are essential, as by the time confirmatory 
tests (bacterial cultures) are positive, the risks of infection having disseminated 
into the blood stream (septicemia) or spread to the meninges (meningitis) are high. 
Hypotension secondary to sepsis can profoundly compromise brain perfusion and 
oxygen delivery, and dramatically increases morbidity; once present, it is often 
refractory to treatment as the underlying mechanisms are multifactorial, including 
the generation of cytokines, and release of toxic metabolites by bacteria.
Hypoglycemia: During transition to extrauterine life, fetal adaptation normally 
enables alternative fuels to be metabolized (lactate, ketone bodies, fatty acids) 
which ensures energy supply to vital organs when blood glucose concentration 
falls. But once born, this ability is down-regulated, especially by oral feeding 
[2], and transitional hypoglycemia can occur. While no single glucose value can 
define hypoglycemia, fully ensure an infant’s safety or limit morbidity, manage-
ment guidelines exist as hypoglycemia can have neurologic consequences [36–38], 
especially when accompanied by seizures, including: motor and/or psychodevelop-
mental delay, microcephaly, seizures, visual impairment, and spastic quadriplegia 
and hemiplegia.
Population data indicate that blood glucose levels as low as 2.0 mmol/L (or even 
1.8 mmol/L at 1 hour of age) are not uncommon in healthy newborns. However, 
various syndromes and metabolic conditions cause or contribute to hypoglycemia. 
Importantly, HI injury can disrupt normal metabolic adaptation, as anaerobic 
glycolysis depletes hepatic glycogen and hyperinsulinism can also occur; there is a 
correlation between lower serum glucose levels and higher Sarnat stages in hypoxic 
ischemic encephalopathy (HIE).
For at-risk infants, outcome data support raising the intervention threshold 
from conventional levels. Current screening and management guidelines are that 
neonates with hypoglycemia persisting beyond the first 72 should be investigated 
further when levels remain ≤2.8 mmol/L, and ≥ 3.3 mmol/L should be the therapeu-
tic glucose target level in symptomatic/at risk infants. Also, before discharge, those 
experiencing persistent hypoglycemia should have a 5-6 hour fast, while maintain-
ing blood glucose levels ≥3.3 mmol/L, to ensure safety at home [39].
Differing patterns of damage now help to distinguish hypoglycemic from HI brain 
injury [5, 40, 41]; the combination on MRI of selective edema in the posterior white 
matter and pulvinar appears specific even in absence of hypoglycemic laboratory 
values. In neonates with concurrent hypoglycemia and HIE, injury is synergistic, and 
the imaging features of both HI injury and hypoglycemia may be detected [5].
Hyperglycemia: A blood glucose concentration > 125 mg/dL (6.9 mmol/L) is a 
common metabolic abnormality encountered in preterm and critically ill newborns 
[42]. Management varies; often iatrogenic, hyperglycemia can cause or aggravate 
brain damage, principally because of the hyperosmolar state that ensues [43].
Hyponatremia in the premature can cause sensorineural hearing loss, cerebral 
palsy, intracranial hemorrhage, and increase mortality following asphyxia [44, 45].
Hypernatremia/hyperbilirubinemia when extreme are neurotoxic. Inadequate 
fluid intake in immature infants and those primarily breast fed is contributory [46, 
47]. Kernicterus selectively damages the globus pallidus and subthalamic nuclei [8, 
48
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compliance with best practices for screening, phototherapy and related treatment is 
required [49, 50].
Seizures: Major causes include brain malformation or structural injury, hypoxia, 
infection and reversible metabolic disorders. Clinical signs vary from subtle move-
ment disorders to focal or generalized, brief or sustained convulsive activity. 
Abnormal movement often involves the eyes (blinking, staring, horizontal tonic 
deviation), mouth (lip smacking or sucking, tongue thrusting), and extremities 
(‘bicycling’, ‘rowing’ or jerking movement). Respiratory (apnea) and cardiac effects 
(tachycardia or bradycardia) occur, often with color change and significant oxygen 
desaturation. Focal clonic seizures may indicate brain damage due to arterial or 
venous infarction. Clinical signs suggesting seizures require confirmatory EEG. MRI 
can distinguish between seizures due to HI events and other causes. Preventable or 
reversible causes include hypoglycemia, hypocalcemia, hyponatremia, hypoxemia 
and acidosis. Seizures do not always imply poor neurodevelopmental outcome for 
affected infants. But the severity of seizures in human newborns with perinatal 
asphyxia is independently associated with brain injury, and not limited to struc-
tural damage detectable by MRI [51]. In term newborns, the predominant pattern 
of watershed and basal nuclei injury after hypoxic ischemic encephalopathy is a 
valuable predictor for later epilepsy; injury to the motor cortex, hippocampus and 
occipital lobe are also independent risk factors, and the severity of brain injury and 
recurrent neonatal seizures elevate risk [52]. Delayed treatment likely increases the 
probability of residual consequences, because of the stresses placed on the brain by 
the high oxygen and substrate requirements implicit when seizures are prolonged.
3. Hypoxic brain injury
As the physiologist Haldane said: “Hypoxia not only stops the machine it wrecks 
the machinery” [2]. A healthy fetus can respond to, and tolerate, the early effects of 
hypoxia, and the degree of acidosis that occurs initially in response to the associated 
retention of carbon dioxide. Acute hypoxia promotes adenosine release, which reduces 
fetal cerebral oxygen consumption via action on neuronal A1 receptors on the cerebral 
arteries, and initiates vasodilatation through activation of A2 receptors; release of 
nitric oxide and opioids and direct effects of hypoxia on the vascular endothelium also 
contribute [53]. As a result, while fetal vascular resistance can decrease up to 50%, 
the net effect is to maintain CBF with only minimal reduction in oxygen delivery; 
but normal or elevated mean arterial blood pressure is critical in parallel, and once 
hypotension ensues the brain suffers from the resulting ischemia.
With moderate HI stress and evolving acidosis, the fetus also has the physiologic 
ability to preferentially perfuse the deep structures of the brain that have higher 
metabolic rates (brainstem, cerebellum, basal ganglia). However, this compensa-
tory redistribution of blood from the anterior to the posterior circulation results 
in the brain’s cortical areas being less well perfused, and hence, if ongoing hypoxia 
remains unrecognized and unrelieved over the course of an hour or more, the end 
result is damage to cortical white matter, and the watershed areas of the cerebral 
hemispheres. In contrast to this partial prolonged pattern of injury, situations 
occur where the HI event is near total in nature and the effect profound. With 
such insults, acidosis develops relatively abruptly, and little or no compensatory 
redistribution of blood to the deep brain structures occurs, because there is no time 
for effective redistribution of CBF to maintain their perfusion. Hence it is the basal 
ganglia and thalami that are predominantly injured, and damage happens over a 
much shorter time frame [9, 54–56]. In the premature, mild to moderate HI injury 
results in periventricular leukomalacia and germinal matrix bleeds, and in full term 
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neonates parasagittal watershed infarcts are seen [55, 57]; severe injury in both term 
and preterm infants involves deep gray matter.
Distinction between partial/prolonged and near total/profound/patterns of 
injury is important from a diagnostic and prognostic standpoint, for understanding 
potential mechanisms for prevention, and over issues of causation in a medico-legal 
context. Modern neuroimaging is the definitive way to distinguish between them 
based on the selective geographic patterns of brain damage caused. Importantly 
however, mixed patterns of injury are also seen that involve both the cortex and 
deep structures [55, 57]. The mechanisms involved can be either superimposed 
insults involving periods of both partial/prolonged and near total/profound injury, 
or, situations where partial and prolonged injury is severe enough to extend to 
involve the deep brain nuclei, or vice versa, when a near total, profound event is 
extensive enough to also involve cortical damage [11, 58].
The time line of near-total HI events can be extrapolated from data obtained in 
animal studies, where fetal monkeys were exposed to complete (i.e. total) hypoxia 
and ischemia, generated by ligating the umbilical cord and preventing breathing. 
These animals could tolerate 10 minutes of HI insult without permanent effects 
if delivered and resuscitated immediately, but, where the HI event was continued 
beyond this 10-minute period for an additional 10 minutes, a progressive and 
cumulative increase in the level of neurological damage was then evident. Where 
the whole insult extended beyond 20 minutes, the fetal monkeys died, in spite of 
delivery and immediate resuscitation.
In applying these data to the human fetus, it is recognized that what occurs most 
often is a near total (profound) interruption of brain blood flow and oxygen delivery, 
rather than an event where hypoxia and ischemia are absolutely total in nature. 
Hence the time-line for tolerance of such events, and the period over which brain 
damage evolves, are accepted as being longer than in the landmark animal studies 
conducted by Myers [59–62]. For this reason, it is generally agreed that approxi-
mately 15 minutes, and possibly up to 20 minutes, of sudden profound asphyxia can 
be tolerated by the human fetus prior to brain damage beginning (in contrast to the 
10 minutes seen in the animal model). Then, after this ‘grace’ period, damage to the 
brain begins to occur, and over a further period of 15 to 20 minutes the extent and 
severity of injury become progressively more profound over time. And beyond this 
time frame, a human fetus is usually born dead. It is important to recognize that the 
principal mechanism that causes fetal asphyxial brain injury is cerebral ischemia 
caused by the severe reduction in CBF that occurs as a result of hypoxic myocardial 
depression significantly reducing cardiac output (CO). The fetal heart has a fixed 
stroke volume, which means that CO, and the amount of blood supplied to the brain 
are a direct function of the rate of contraction; so, for example, with bradycardia 
where fetal heart rate slows to half normal, this equates to a 50% fall in CO, and 
a comparable reduction in CBF will result. CO also decreases where tachycardia 
accompanies hypoxic stress; at high heart rates poor contractility secondary to 
acidosis is then compounded by incomplete atrial filling in diastole.
The relationships between the geographic pattern of asphyxial brain injury and 
type of resulting disability have been defined [63], and the predictors of long-term 
morbidity delineated [64]. Near-total insults of moderate duration and degree 
which have the basal ganglia and thalamic pattern of damage, predominantly lead to 
athetoid or dystonic cerebral palsy, with intact or mildly impaired cognitive develop-
ment. When severe, near-total insults damage the cerebral cortex in addition to the 
deep brain structures; and severe spastic quadriplegia results, with microcephaly, 
significant cognitive deficits and cortical visual impairment. The extent of injury is 
strongly associated with the intensity of resuscitation, the degree of encephalopathy, 
and severity of seizures [55, 65]. Prolonged partial insults of moderate degree with 
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injury confined to watershed regions cause variable degrees of cognitive deficit and 
epilepsy, and can be associated with spastic quadriplegia. But, when more severe or 
prolonged, injury causes extensive cortical brain involvement, or global brain injury; 
the end result is spastic quadriplegia, severe cognitive impairment, cortical visual 
impairment, and microcephaly. In addition, symptomatic brainstem involvement can 
be associated with severe patterns of injury, and lead to non-survival [66].
Hypoxic ischemic encephalopathy (HIE) is a clinically defined syndrome of 
disturbed neurological function in the earliest days of life, caused by intrapar-
tum or late antepartum brain hypoxia and ischemia [67]. HIE evolves clinically 
following significant HI insult, and is a major predictor of neurodevelopmental 
disability. HIE develops in 1 to 8 per 1000 live births in developed countries, and 
up to 26 per 1000 worldwide [65, 67]; not all cases of neonatal encephalopathy 
are due to anoxia or HI injury [8, 58], but epidemiological studies confirm the 
association of HIE with pregnancy related risks, and intrapartum risk factors that 
predispose the fetus to hypoxia; 15-20% of affected infants die; in about 25% of 
survivors permanent neurologic deficits remain. Prospective studies employing 
MRI suggest that the majority of HIE occurs as a result of HI insult and brain 
injury at or near the time of birth [41]. Postnatal exacerbation of intrapartum 
acquired injury occurs relatively rarely (10%), but is a potentially preventable 
component in many instances [11, 67].
Hallmarks of neonatal encephalopathy are neurological depression, with altered 
level of consciousness and often respiratory depression, abnormal muscle tone and 
power, disturbances of cranial nerve function, and seizures. HI injury is strongly 
suggested in a neurologically depressed infant by associated acidosis, and further 
confirmed by concomitant multi-organ injury [58, 65, 68].
Acidosis has two components: respiratory  - from retained carbon dioxide, and 
metabolic - from accumulation of fixed acids (lactic acid and β-hydroxybutyrate). 
While acidosis present at birth usually resolves in the first hours of life,  HIE pro-
gresses with further depression of consciousness, abnormalities in tone and move-
ment, and onset of seizures. Infants exhibit a range of behaviors and alterations 
of conscious level from lethargy and obtundation to irritability and a hyper-alert 
state. Similarly, disorders of tone range from a marked decrease to hyper-tonicity. 
Abnormal movements include tremors, jitteriness, mouthing and blinking, and 
‘bicycling’ of the legs, through to frank seizures. Other manifestations include 
apnea, with bradycardia and impaired oxygen saturation, shrill cry, feeding dif-
ficulty (due to poor coordination of suck or altered peristalsis, and occasionally 
brain stem damage), absence of the Moro and/or gag reflexes, and exaggeration of 
deep tendon reflexes. Decerebrate or decorticate posturing may be seen. Sarnat et al. 
defined three levels of severity (mild, moderate and severe); these are linked to the 
probability that HIE will result in permanent neurological consequences [69].
The pathophysiology of HIE is now better understood and treatment with 
hypothermia has become the foundation of therapy [67]. All affected infants 
require supportive management that anticipates and limits the adverse effects on 
the brain of fluctuations in cerebral perfusion, metabolic instability, sepsis, sub-
optimal respiration, and any situation that increases oxygen and energy demands. 
This involves correction of hypotension, attention to glucose, fluid and electrolyte 
homeostasis, maintenance of PaCO2 in the normal range, and treatment of seizures 
[58, 67]. Neuroimaging (US, CT, MRI) is best done at defined periods after injury 
[41, 57]; MRI in particular can then define the diagnosis, pattern, severity, timing 
and prognosis, and help rationalize hypothermia and other interventions, including 
the withdrawal of support. Several neuroprotective agents that can be combined 
with hypothermia have entered clinical trials; new biomarkers for HIE are being 
sought [70]. Affected survivors need follow up to manage their handicaps.
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4. Multisystem involvement secondary to hypoxia
The effects of hypoxia extend beyond the brain [9, 11, 67, 68], associated injury 
to other organs principally occurs due to compensatory redistribution of blood 
during partial and prolonged insults, but can follow profound, near total episodes; 
60-80% of affected neonates exhibit single or multiple organ injury [68].
The fetus often passes meconium (fetal bowel contents) in utero due to hypoxia; 
a combination of gut ischemia and reduced sphincter tone secondary to neuro-
logical depression is the likely mechanism, hence, the presence of meconium is a 
marker for probable HI. Following a recent event, meconium seen is usually thick 
and green; after a remote event, because mixing with amniotic fluid disperses 
and thins the meconium, the liquor is evenly discolored, and the fetal skin may be 
stained green.
In the neonate, multiple organs can show varying effects from hypoxia.
The lungs can be injured directly and indirectly; inhaled meconium, surfactant 
depletion, pulmonary hypertension and left ventricular failure can all result in 
impaired gas exchange and the need for assisted ventilation. The risks of brain 
injury increase where such effects are superimposed on the poorly compliant lungs 
of a preterm infant. A pneumothorax (air leak into the pleural space) causing lung 
compression and elevated intrathoracic pressure is less common with modern 
ventilation techniques, but when it occurs, major disturbances in cerebral perfusion 
pressure result that increase the risk of brain ischemia and hemorrhage.
The heart can suffer functional and structural damage; acidosis seriously 
impairs myocardial function, myocardial ischemia further compromises conduc-
tion and mechanical contractile efficiency; affected neonates often require fluid 
resuscitation at birth and inotropic agents (dobutamine/dopamine) to maintain 
their circulation. Abnormalities on ECG and echocardiogram, and elevated cardiac 
enzymes (creatine kinase–MB fraction/troponin T levels) reflect heart dysfunction 
and damage.
The kidneys: Absent or significantly reduced urine output in the 24 hours 
following HI is common, associated hematuria indicates renal tubular damage. 
Renal injury is the best systemic marker of potential brain injury when oliguria 
(urine output <1 ml/kg/h) is associated with an abnormal neurological exam [68]. 
Blood urea and serum creatinine rise progressively and peak in the days following 
injury. Inappropriate secretion of antidiuretic hormone (ADH) causes hyponatre-
mia; hypoxia stimulates the carotid body chemoreceptors to secrete ADH which 
causes fluid retention, and a secondary fall in serum sodium concentration.
The liver: Elevated enzymes reflect hepatic cellular damage; lactate dehydroge-
nase (LDH) is the best hepatic predictor of HIE (sensitivity 100% and specificity 
97%), and also of long-term outcome after HIE [71]; blood glucose concentration 
can fluctuate, with hypoglycemia being most common [72].
Bone marrow: Increased release of nucleated (immature) red blood cells (NRBC) 
and reduction in platelet numbers (thrombocytopenia) reflect hemopoietic effects. 
After HI, platelets numbers fall by 12 hours, with the nadir at 2-3 days [2], while 
NRBCs peak in the hours after birth and fall by 50% after 12 hours [73]; distinct 
patterns relate to timing of HI [74]. Hypoxic events likely induce exaggerated eryth-
ropoiesis as a compensatory response, with release of NRBCs into the fetal circula-
tion. Elevated NRBCs are associated with intrapartum fetal distress and acidemia at 
birth secondary to hypoxia, with a direct correlation reported between decreasing 
UA pH and NRBC elevation in the term human fetus. Newborns with elevated 
NRBCs suffer a significant increase in both short-term morbidity and mortality and 
long-term disability [75]. NRBC counts are best given as an absolute number per unit 
volume rather than relative to 100 white blood cells as this avoids misleadingly low 
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values when wbc counts are high; published values indicate normal counts decrease 
with advancing gestation and increasing birth weight [73, 74]. A value >1000/mm3 
(or > 10-20/100 wbc) in the first hours of life is considered elevated [73]; A prospec-
tive case-controlled study identified that a NRBC count of >13/100 leukocytes had a 
sensitivity of 81.3% and a specificity of 94.4% in predicting adverse outcomes [76]. In 
neonates subsequently cooled, those with absolute NRBC counts >1324/mm3 within 
6 hours of birth had high risks of abnormal MRIs and adverse 2-year outcomes; 
the combination of NRBC count and other early markers, such as lactate levels and 
EEG, could increase the overall predictive ability [77]. The magnitude of increase in 
NRBCs is a function of the severity and duration of asphyxia, and a reliable index of 
perinatal brain damage [73–77].
Metabolic markers: Plasma lactate is an important marker for recent tissue 
hypoxia; lactate is a metabolite in aerobic metabolism, and measurements in arte-
rial blood at 30 minutes of life show lactate to be as equally valuable as base deficit 
in assessing the severity of birth asphyxia; elevated concentrations >9 mmol/l are 
associated with moderate or severe encephalopathy and PVL (sensitivity 84% and 
specificity 67%) [78]. Low serum calcium and elevation of bilirubin can also occur.
Gastrointestinal tract: abnormal peristalsis underlies feeding intolerance after 
hypoxia, and the risk of necrotizing enterocolitis is increased [68]. Infants also feed 
poorly due to an impaired rooting reflex, reduced tone, diminished coordination 
and drowsiness; associated cranial nerve and brain stem lesions contribute.
5. Adjuncts to comprehensive care
Fetal ultrasound (US): Endovaginal ultrasonography has become the standard 
imaging measure in pregnancy. US uses pulsed high-frequency sound to produce 
images and employs terminology and standardized interpretations based on defined 
criteria to ensure safe maternal examination, and prevent inadvertent harm to early 
normal pregnancy [79]. US provides routine confirmation of gestational age/due date, 
detects fetal anomalies, oligo or polyhydramnios, and provides assessment of fetal 
growth parameters in early pregnancy [80]. Protocols also exist for the management 
of specific clinical scenarios that pose a risk for the fetus and require increased fetal 
surveillance; these allow for appropriate referral when complications are suspected, 
e.g. for intrauterine growth retardation, and monochorionic dichorionic twin gesta-
tion where there is a high risk of twin-to-twin transfusion syndrome developing [81].
Fetal scalp blood sampling: can assess the evolution of hypoxia and acidosis via 
blood gas measurement or lactate analysis, once the membranes have ruptured and 
the fetal head has descended into the birth canal during the later stages of labor.
Fetal heart rate monitoring (EFM): The physiologic perturbations in fetal 
oxygenation and hemodynamics that changes in fetal heart rate (FHR) reflect, 
provide the rationale for FHR measurement and EFM intrapartum [56]. With onset 
of hypoxia, physiological effects on the fetus usually generate detectable changes in 
fetal heart rate pattern, as the myocardium is sensitive to reduced oxygen tension, 
elevated carbon dioxide, and progressive evolution of acidosis. From a preventive 
standpoint the importance of EFM is that clinically relevant FHR changes are usually 
evident before the brain is affected sufficiently for permanent damage to begin.
Assessment at birth: Transition to extra-uterine life is physiologically complex. 
Where needed, resuscitation must mitigate any residual effects of compromised 
organ function or intrapartum events that have depressed or damaged the brain. A 
key element in reducing morbidity is the immediate availability of skilled person-
nel able to provide the well-established neonatal life support (NALS) priorities for 
resuscitation [68], assess the history, intrapartum events and clinical status of the 
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infant, and order the level of care and specific diagnostic and treatment entities 
required.
Apgar score: Named for Virginia Apgar, this is intended as an objective index 
to evaluate the condition of a newborn infant based on a rating of 0, 1 or 2 for each 
of the five components: color, heart rate, response to stimulation of the sole of the 
foot, muscle tone, and respiration. Scores are determined by observing/examining 
the newborn infant in real time at 1, 5 and 10 minutes of age. Scores principally 
gauge progress in response to resuscitation; persistently low scores equate with 
failure to respond, and imply the newborn has significant physiologic problems. 
Apgars were not meant to be an outcome parameter. Also, retrospectively estimated 
scores are problematic when they do not match contemporaneous event descriptors 
in the resuscitation record. Care with interpretation is also required where an infant 
is premature due to an associated degree of physical immaturity, and where active 
life support (e.g. assisted ventilation) is generating the improvements observed.
Umbilical cord blood gas analysis: Fetal oxygenation and acid base status can 
be assessed from paired blood samples collected from the umbilical vein (UV) and 
arteries (UA) at birth; this is an integral part of monitoring high-risk deliveries 
[82], but an understanding of fetal placental perfusion and how specific condi-
tions affect values are necessary for accurate interpretation. Cord compression, for 
example, is associated with normal values when acute and complete, in spite of the 
infant being profoundly acidotic systemically, as they reflect fetal status when cord 
flow ceased. In contrast, partial restriction causes UA and UV values to progres-
sively widen, and with impaired maternal placental perfusion UA/UV differences 
are small [82, 83].
Normally, oxygenated blood from the placenta flows through the UV and prefer-
entially supplies the fetal brain and heart via shunts that bypass the liver; repeated 
uterine contractions during labor exert a significant, but manageable metabolic 
stress on the fetus. But when labor is precipitous, or contractions are abnormally 
frequent or prolonged, uterine artery blood flow becomes restricted, and inter-
contraction restoration of placental perfusion is delayed as it is dependent on uterine 
relaxation; in this and similar scenarios maternal to fetal oxygen transfer via the UV 
can suffer sufficiently for HI injury to occur. Where blood return through the UA is 
also affected, normal removal of carbon dioxide from the fetus is reduced.
Acidosis occurs as a consequence of cellular hypoxia (inadequate oxygenation), 
tissue ischemia (inadequate blood flow) and retention of carbon dioxide; the unit 
of measurement, pH, is on a logarithmic scale, so small differences represent a 
major change in the degree of acidosis. Bicarbonate naturally buffers acid produc-
tion; as reserves are depleted, base deficit increases. With resolution of acidosis, 
PCO2 values are restored first, followed by bicarbonate and pH; base deficit remains 
abnormal longest. Normal cell metabolism only occurs when pH is held within a 
narrow range, beyond these limits, cells progressively lose their ability to sustain 
normal function and maintain their metabolic integrity, and organs begin to fail.
Blood gas data are compared to the reference range of the testing laboratory. 
Significant, recent HI stress usually manifests with low oxygen, elevated PCO2, low 
pH, low bicarbonate and high base deficit, with UA values most affected. However, 
it is most relevant clinically to define pathological acidosis as the threshold at which 
the incidence of adverse events starts to correlate strongly [83]. Criteria to define an 
acute intrapartum event as sufficient to cause cerebral palsy include UA pH <7.00 
and base deficit of >12; infants with a pH <7.0 who are not vigorous are at high 
risk of adverse outcome [84], and the threshold for moderate or severe newborn 
complications is defined as a UA base deficit of >12 [85]. With worsening acidosis 
progression of adverse sequelae rises sharply; in one reported series, HIE occurred 
in 12% of infants with cord pH <7.0, in 33% with pH <6.9, and in 80% with pH 
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<6.7; a pH <6.8 equated with the probability of neonatal death [86]. Persisting lactic 
acidosis is associated with severe encephalopathy [82]. Identifying those at risk is 
especially important now, since neuroprotection strategies are available.
Hematology: White blood cell (wbc) counts can be strongly indicative (but 
not always diagnostic) of the presence of infection. Elevated total wbc numbers, 
a high proportion of neutrophils (granulocytes), and elevated primitive (band) 
cells indicate that stimulation of the bone marrow by inflammatory cytokines has 
occurred; very low counts often indicate inability to mount an effective immune 
response. Elevation of band cells is the earliest change in response to inflammatory 
stimuli, although hypoxia can also result in an increase in band cell number [87].
Hemoglobin concentration and hematocrit are used to identify anemia and 
polycythemia where too few or too many red cells are circulating respectively. Both 
circumstances compromise oxygen delivery; anemia by limiting the amount of 
oxygen that can be transported, and polycythemia by reducing the ease with which 
blood flows, which also increases the risk of blood vessel occlusion (thrombosis), 
and is one of the mechanisms underlying stroke. Also, by following serial mea-
surements from birth, situations can be identified where bleeding occurred while 
the fetus was in utero. After significant blood loss, the volume of the blood in the 
circulation is reduced, but the hemoglobin concentration remains the same initially, 
then, as physiological compensation for the blood lost occurs, fluid is drawn into 
the circulation to restore blood volume and, as a consequence, hemoglobin concen-
tration and the number of red cells per unit of volume (hematocrit) fall.
Blood chemistry: Electrolyte and glucose measurements, in parallel with 
blood gas analysis of pH, oxygen and carbon dioxide tension, bicarbonate and base 
deficit, plasma lactate, serum calcium and liver transaminases are the mainstays of 
clinical monitoring in brain injured infants, particularly when multisystem involve-
ment complicates the course of neonatal encephalopathy. A small but complex 
group of congenital metabolic abnormalities causing neonatal encephalopathy 
exist [58]; these require expert assessment, comprehensive investigation and 
management.
Neuroimaging: Modalities include ultrasound, computerized tomography and 
magnetic resonance imaging [55, 88]. US provided the initial method for imaging 
brain structures and is still clinically attractive because of the ability to study sick 
pre-term infants in the nursery. The advent of CT greatly advanced knowledge of 
brain development and injury. But MRI is now the imaging modality of choice, in 
spite of cost, due to the lack of ionizing radiation and its superior sensitivity and 
specificity in detecting brain abnormalities. CT remains relevant for infants too sick 
for MRI. MR image interpretation needs to be as sophisticated as the technology.
Magnetic resonance imaging (MRI) is now invaluable in assessing the neonatal 
brain following suspected perinatal injury. Imaging during the first week of life is 
prognostic and can aid management decisions. MR imaging is an excellent predictor 
of outcome following perinatal brain injury; characteristic lesions and patterns of 
changes are at their most obvious on conventional imaging between 1 and 2 weeks 
from birth [7]. Diffusion-weighted imaging (MRI sensitive to water diffusion) 
allows early identification of ischemic tissue; associated restricted diffusion on day 
3 of life implies injury was acquired around the time of birth, and is not the late 
manifestation of remote in utero injury sustained during the third trimester [6]. 
However, DWI may underestimate the final extent of injury, particularly in basal 
ganglia and thalamic lesions. The outstanding contrast resolution of MRI, superim-
posed on the ability to image in any plane, means even subtle brain malformations 
are identified.
Like US and CT, MRI scans are best done at defined intervals after birth (3-5 and 
10-14 days of life) for accurate diagnosis, timing and evolution of injury [55, 57]. 
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Pathology identified includes structural developmental abnormalities, edema, hemor-
rhage, early ischemic damage, localization of the predominant injury to either cortical 
tissue or deep brain structures, the evolution and end stages of scarring, and, onset 
and progression of hydrocephalus or microcephaly. Importantly, intrapartum and 
late antepartum HI damage can be distinguished from congenital structural effects 
or lesions due to acquired causes that occurred well prior to birth, so MRI scans can 
identify damage caused to an otherwise normal and pristine brain.
MRI, magnetic resonance spectroscopy, and diffusion-weighted MRI have iden-
tified the patterns of brain injury that evolve after HI insults. Studies also define the 
severity of the insult and can indicate the age at which it probably occurred. Injury 
evolves over days, if not weeks before the final stage with scarring is evident. The 
anatomical regions of the brain affected define the mechanism of injury. Distinction 
can be made between an insult that involved a relatively short period of total or 
near total hypoxia/ischemia (profound hypotension), or one occurring over a more 
prolonged period where HI was partial in degree (moderate hypotension).
In near total insults, the most metabolically active brain structures are damaged; 
the lentiform nuclei, especially the posterior putamina, the ventrolateral thalami, 
the Rolandic cortex and the hippocampi are predominantly injured, while there is 
little or no involvement of the remainder of the cerebral cortex.
In contrast, in partial and prolonged hypoxia, cortical white matter integrity is 
compromised, and there is relative preservation of the basal ganglia and thalami. 
In severe cases the whole cortex may be involved, while with milder injury, the 
principal areas damaged are the interfaces between the perfusion zones of the 
anterior, middle and posterior cerebral arteries. An excellent schematic derived 
from a medicolegal database of MR images of term neonates with partial-prolonged 
HI injury illustrates the geography of the inter-arterial watershed zone [89].
While these are the two distinctive and predominant patterns of HI brain injury 
seen, in reality, the type, pattern, duration and variability in severity of HI are a con-
tinuum, so there is a spectrum of MRI findings, and mixed patterns of damage are 
seen, with changes of varying degree in both the basal ganglia thalami and cortical 
regions [55, 57]. Very severe injury from moderate or profound hypotension can also 
cause global brain involvement, and extend to include the brainstem [66].
MRI detectable changes take time to evolve; the first abnormality seen is diffusion 
restriction which peaks at about 72 hours [57]; brain edema, identified as T2 hyper-
intensity, reflects the progression of energy failure that follows brain cell damage, 
and precedes cell death due to the apoptosis necrosis continuum. Where there is 
significant involvement of the cortex, abnormal T1 hyperintensity is evident from 
about 1 week following the HI event; this can persist for several weeks. T1 hyperin-
tensity due to basal ganglia damage is visualized over a similar time frame. The end 
result of injury is permanent scaring (gliosis), and compensatory enlargement of the 
ventricles (ventriculomegaly) [7, 55, 57].
Destructive lesions characterized by periventricular hyperintensity, focal defects 
in the germinal matrix, and areas of abnormal signal intensity occur in developing 
white matter. In encephalopathic term newborns, non-cystic white matter injury is 
a distinct and common pattern. A helpful sign in those >37 weeks gestation is loss of 
normal signal intensity in the posterior limb of the internal capsule. Hemorrhage is 
associated with hypointense areas; signal intensity depends on degree of evolution.
Periventricular leukomalacia can develop during fetal life and in the newborn 
period. Imaging predominantly identifies PVL  in preterm infants, but importantly, 
lesions  also occur in term and late preterm infants (those born between 34 weeks 
and 0 days and 36 weeks plus 6 days gestation) [90].
Fetal MR imaging is a technique that complements prenatal sonography as it 
has higher contrast resolution and allows direct visualization of the fetal brain, and 
17
Pathogenesis and Prevention of Fetal and Neonatal Brain Injury
DOI: http://dx.doi.org/10.5772/intechopen.93840
hence more readily identifies both cerebral malformations and destructive lesions, 
including agenesis of the corpus callosum, cerebellar dysplasia, germinal matrix 
hemorrhage, IVH, multicystic encephalomalacia, periventricular leukomalacia, 
periventricular nodular heterotopias, porencephaly, and sulcation anomalies. For 
post-natal studies, diffusion-weighted MR imaging and proton MR spectroscopy 
are the most sensitive modalities for diagnosis in the early hours following injury.
Future advances in MRI hardware and software will likely enable neuroimaging 
technologies to contribute more by further delineating the site(s), progression and 
extent of injury; this will aid evaluation of causation and timing, and advance care 
strategies able to reverse or mitigate the long-term effects of perinatal brain injury.
Electroencephalogram (EEG): Patterns of brain waves obtained allow the 
location and relative severity of various brain pathologies to be identified. Seizure 
activity occurring in the brain but not visible clinically is detected. Patterns of 
depression of cortical brain activity on EEG have been defined that are associated 
with varying stages and severity of HIE [69]. Serial measurements document the 
evolution of, and recovery from, abnormal brain function and the effect of therapy.
Placental pathology: Examination of the placenta is an integral part of 
investigation of fetal brain injury and neonatal encephalopathy [67]. Pathology 
provides key information related to the fetus, and causal mechanisms underlying 
intrapartum events [91] e.g. fetal distress, chorioamnionitis and hemorrhage; and 
to maternal conditions that affect placental function and fetal oxygenation e.g. 
hypertension and diabetes. Evidence of placental insufficiency links to fetal growth 
retardation and increased risk of fetal distress. Any significant disturbance of pla-
cental gas exchange and fetal perfusion poses risks of brain injury; examples include 
pre-eclamptic toxemia, hemorrhage from placenta previa, uterine tachysystole, 
cord compression and placental abruption [92–94]; abruption is the commonest 
identifiable antecedent factor for injury in preterm infants with HIE. Examination 
can also identify causal pathology in the absence of a ‘sentinel event’ [67] and in 
circumstances where the umbilical cord is vulnerable e.g. abnormal insertion, tear-
ing, true knots, prolapse, occlusion, and entrapment, each of which causes recog-
nized adverse consequences for fetal oxygenation. Decreased placental maturation 
is associated with increased risk of white matter/watershed injury with or without 
basal ganglia/thalami involvement, and chronic villitis with basal ganglia/thalami 
injury irrespective of white matter injury [93].
6. Prevention of brain injury
Prevention of brain damage requires knowledge of the etiologies underlying 
injury, awareness of the availability of preventive measures, and timely employ-
ment of them to address the underlying cause. In addition, situations that may 
aggravate existing or evolving brain injury need to be anticipated, recognized, and 
appropriate evidence-based care provided that is capable of improving outcome.
Maternal and paternal medical history and lifestyle: Maternal nutrition and 
trace element status, the health and age of both parents at conception, and other 
factors related to current developmental origins of health and disease (DOHaD) 
concepts are all relevant to prevention [4, 95]. The risk of fetal brain injury is 
decreased where mothers maintain a good diet, add folic acid and iron plus required 
prenatal supplements (vit. D, calcium), avoid smoking and the detrimental effects 
of alcohol and drugs, and exposure to TORCH infections is prevented. There are 
benefits to becoming a mother earlier rather than later in life, and from both parents 
having lifestyles that promote physical health and mental wellness especially at 
conception.
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Antenatal care is central to optimizing the fetal environment, monitoring 
maternal health, detection of entities that require intervention or forward plan-
ning, and enabling pregnancy to progress to term. Care should ensure that fetal 
growth progresses normally, all indicated US and lab studies are done, necessary 
referrals are made, and parents prepared appropriately. Prevention of brain injury 
centers on labor and delivery, but relies on attention to multiple factors throughout 
pregnancy. The fetal brain probably benefits most from prevention of avoidable 
preterm delivery, and therapy such as antenatal steroid use to mature the fetal lung 
when prematurity is inevitable. Post maturity with the inherent risks of placental 
failure and increased fetal morbidity must be avoided, especially where at risk 
situations exist such as gestational diabetes. Prior cesarean section requires special 
planning and supervision, to avoid uterine complications that can jeopardize fetal 
wellbeing.
Monitoring during pregnancy: Confirmation by US of gestational age reduces 
premature delivery; monitoring of fetal growth parameters anticipates intrauterine 
growth retardation, and can identify placental anomalies that increase morbidity. 
Genetic screening can detect anomalies linked to brain defects; termination of preg-
nancy is a care option when a fetus is known to have a major anomaly. Surveillance 
for a broad range of maternal illnesses is possible with investigative protocols and 
preventive entities available to optimize maternal care and fetal health, and select 
appropriate timing, mode and location of labor/delivery.
Advance consultation with obstetric and neonatal referral centers should occur 
where necessary to obtain advice regarding priorities for care and delivery.
Transport with the fetus in utero should occur if care at a higher level is 
required to optimize the logistics of delivery and provide for a good neonatal 
outcome [2].
Intrapartum care: Guidelines exist in most jurisdictions based on the evidence 
base for best practice in obstetric management where the health of the mother 
and/or fetus becomes at risk. Monitoring of maternal and fetal wellbeing requires 
entities that provide for anticipation, detection and management of complications, 
particularly those linked to maternal emergencies and/or generate fetal distress; 
e.g. placental insufficiency, failure or abruption, hemorrhage, hypo or hyperten-
sion, uterine tachysystole or rupture, obstructed labor, or cord compromise. 
Importantly, a non-reassuring electronic fetal heart rate pattern, or changes in 
FHR reflecting alteration in fetal cardiac function, usually occurs prior to brain 
metabolism being affected sufficiently for neurological damage to begin. Hence, 
recognition of a ‘non-reassuring’ tracing, a ‘sentinel event’ involving fetal heart 
function, or a pattern known to be associated with pathology (e.g. cord compres-
sion) [84], allows prompt assessment, and instigation of interventions required to 
relieve compromised fetal oxygenation, expedite instrumental delivery, or do an 
emergency cesarean section.
Staff with the required skills must be available to comprehensively resuscitate 
any sick newborn, and promptly address residual morbidity after delivery. Skill 
with assisted ventilation is important, as prevention of detrimental hyperoxia and 
hypocarbia reduces brain injury risk in premature infants, and improves outcome in 
any sick neonate where hypoxia and ischemia have occurred [67]. After appropriate 
resuscitation, all the care entities required to minimize the possibility of a brain 
injury being sustained, or an existing intrapartum injury compounded, must be 
provided. Priorities to do this include: support of respiration and the circulation; 
provision of a neutral thermal environment, appropriate hydration and nutrition; 
prophylactic antibiotics and management of proven infections; hematological and 
biochemical surveillance; and neuroradiological monitoring. Good communication 
and support of the physical and mental wellbeing of both parents must be ensured.
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Controlled hypothermia is indicated where HIE develops; the concept of 
cooling being beneficial stems from animal studies and the neuroprotective effects 
of hypothermia in children following near-drowning and during cardiac surgery. 
Interventions to minimize the effects of hypoxia and HIE postnatally continue to 
evolve; early studies of short periods of cooling had limited, contradictory results. 
Later studies were more promising; where cerebral hypothermia was initiated after 
HI insult, and before onset of secondary energy failure, newborns with moderate 
encephalopathy had better neurodevelopmental outcome compared to normothermic 
controls [96]. Neuroprotective hypothermia for neonatal encephalopathy has been 
the subject of systematic review [97]; it is currently the standard of care for moderate 
and severe HIE; improves survival without CP or other disability by 40%; and cur-
rent protocols are considered near optimal. Therapy within 6 hours of age at 33–34°C, 
continued for 72 hours, decreases death or disability at 18 to 24 months of age and 
increases the number of normal survivors [8, 67, 97]. Defined obstetric antecedents 
indicative for cooling include umbilical cord prolapse, uterine rupture and placental 
abruption [98]. In cooled encephalopathic newborns, time to recovery of amplitude 
integrated EEG is a good predictor of outcome [8]; early MRI scans (3-6 days of 
life) robustly predict the predominant pattern and extent of injury, and late scans 
(10-14 days) long-term outcome, and the predictive value of MRI is not affected by 
hypothermia [99, 100].
In future, earlier initiation of cooling after resuscitation may prove beneficial; 
ongoing research aims to identify other neuroprotective approaches that can be 
used in parallel, and evaluate potentially beneficial therapeutic agents; ways that 
may help reduce the incidence of IVH during rewarming are also being explored.
7. Conclusion
Many causes of fetal and neonatal brain injury are now preventable. The con-
sequences of cerebral hypoxia and ischemia remain considerable. Evidence-based 
care strategies during pregnancy and for premature and sick newborns infants are 
improving outcome.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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